NLRP3 and metabolic disease: In Nlrp−/− mice, reduced NLRP3-inflammasome activity inhibits liver damage, whereas inhibition of autophagy stimulates the NLRP3 inflammasome to promote inflammatory states and metabolic disorders [61].